Is the pretreatment effect of low dose Freund's adjuvant on adjuvant arthritis due to an activation of the nervous system?
It has been recently shown that pretreatment with a low dose of Freund's adjuvant decreases the severity of adjuvant arthritis in rats. To study the involvement of the central and peripheral nervous systems in the pretreatment effect, concentrations of substance P (SP)-, neurokinin A (NKA)-, calcitonin gene-related peptide (CGRP)- and neuropeptide Y (NPY)-like immunoreactivities (-LI) were measured in the cerebrospinal fluid, plasma and synovial fluid 2 and 24 h after a single s.c. injection of 0.05 mg Freund's adjuvant. Increased concentrations of CGRP-LI were found in the cerebrospinal fluid, plasma and synovial fluid. NPY-LI was decreased in the cerebrospinal fluid while NKA-LI was decreased in plasma. In the synovial fluid, SP-LI was increased at 24 h and NKA-LI was increased at 2 h following treatment. Our results indicate that part of pretreatment effect of low dose of subcutaneous Freund's adjuvant in the rat may be attributed to neurogenic mechanisms.
Bileviciute
I
I
Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden.
Theodorsson
E
E
Lundeberg
T
T
D000818:Animals; D001169:Arthritis, Experimental / Q000276:immunology / Q000503:physiopathology*; D015740:Calcitonin Gene-Related Peptide / Q000378:metabolism; D005620:Freund's Adjuvant / Q000008:administration & dosage*; D007114:Immunization; D008297:Male; D015288:Neurokinin A / Q000378:metabolism; D009478:Neuropeptide Y / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013373:Substance P / Q000378:metabolism; D013582:Synovial Fluid / Q000378:metabolism
D009478:Neuropeptide Y; D013373:Substance P; D015288:Neurokinin A; D005620:Freund's Adjuvant; D015740:Calcitonin Gene-Related Peptide